Market Closed -
Other stock markets
|
After market 01:20:55 pm | |||
2.82 EUR | +1.81% | 2.85 | +1.06% |
09:04am | BRAIN Biotech AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 | CI |
Apr. 16 | Brain Biotech Plans Merger by Absorption of AnalytiCon Discovery | MT |
Sales 2024 * | 62.56M 68.06M | Sales 2025 * | 70.97M 77.21M | Capitalization | 60.52M 65.84M |
---|---|---|---|---|---|
Net income 2024 * | -3M -3.26M | Net income 2025 * | - 0 | EV / Sales 2024 * | 1.36 x |
Net Debt 2024 * | 24.73M 26.91M | Net Debt 2025 * | 23.42M 25.48M | EV / Sales 2025 * | 1.18 x |
P/E ratio 2024 * |
-17.3
x | P/E ratio 2025 * |
-159
x | Employees | 311 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.38% |
Latest transcript on BRAIN Biotech AG
1 day | +2.89% | ||
1 week | +4.01% | ||
Current month | +1.79% | ||
1 month | +2.52% | ||
3 months | -28.75% | ||
6 months | -24.00% | ||
Current year | -22.13% |
Managers | Title | Age | Since |
---|---|---|---|
Adriaan Moelker
CEO | Chief Executive Officer | 60 | 20-01-31 |
Director of Finance/CFO | 54 | 20-04-30 | |
Alexander Pelzer
CTO | Chief Tech/Sci/R&D Officer | 38 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Majerus
CHM | Chairman | 63 | 19-03-06 |
Stephen Catling
BRD | Director/Board Member | 59 | 20-10-13 |
Director/Board Member | 70 | 20-10-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 2.82 | +1.81% | 27 239 |
24-05-27 | 2.77 | +0.36% | 8,037 |
24-05-24 | 2.76 | +1.10% | 18,454 |
24-05-23 | 2.73 | -0.36% | 18,454 |
24-05-22 | 2.74 | 0.00% | 11,014 |
Delayed Quote Xetra, May 28, 2024 at 08:08 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.13% | 65.72M | |
-21.84% | 236M | |
+28.46% | 71.77M |
- Stock Market
- Equities
- BNN Stock